Trials in Philadelphia, Pennsylvania
Here are the top 10 medical studies for lung cancer in Philadelphia, Pennsylvania
Popular Filters
Phase 3 Trials
Chemotherapy
High-Dose Radiation + Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
West Reading, Pennsylvania
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Alkylating agents
Furmonertinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Langhorne, Pennsylvania
This trial is testing furmonertinib at two different doses to treat a specific type of lung cancer. It targets patients with advanced or metastatic non-squamous NSCLC who have a particular genetic mutation. The medication works by blocking a protein that helps cancer cells grow, potentially slowing down or stopping the cancer.
Anti-tumor antibiotic
ONC-392 vs Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
East Brunswick, New Jersey
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Ramucirumab + Pembrolizumab vs Chemotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Newark, Delaware
This trial compares ramucirumab+pembrolizumab vs chemo for non-small cell lung cancer. Ramucirumab+pembrolizumab may stop tumors from growing and spreading, while chemo kills/stops cells from dividing/spreading. Results may help find out if this combo is more effective than chemo.
Trials With No Placebo
Monoclonal Antibodies
SGN-BB228 for Melanoma
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug called SGN-BB228 to see if it can help treat difficult-to-treat cancers like melanoma and other solid tumors. The study will determine the safest amount of the drug to give and check if it works in shrinking or eliminating these tumors. The goal is to find a new treatment option for patients whose cancers are not responding to current therapies.
PD-1/PD-L1 Inhibitor
Cemiplimab + BNT116 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
New York, New York
This trial is testing a new drug combination of BNT116 and cemiplimab for patients with advanced lung cancer. It aims to see if this combination is safe and works better than cemiplimab alone. The study will also check for side effects and how the body reacts to the drugs.
Antibody-drug conjugate
Vobramitamab Duocarmazine for Prostate Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing an experimental drug (MGC018) for mCRPC patients who have had prior ARAT and taxane-containing treatment. 150 participants will be randomized 1:1:1 in Phase 2, and 270 will be randomized 1:1 in Phase 3.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.